Recording Webinar: Continuous Verification in Pharmaceutical Analysis

Recording Webinar: Continuous Verification in Pharmaceutical Analysis

Costs

ECA-Member: EUR 199,--
Non ECA Member: EUR 249,--

(All prices excl. VAT)

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@concept-heidelberg.de

Speakers

Dr Joachim Ermer, Sanofi, Frankfurt, Germany

Background

According to the FDA-Guidance „Analytical procedures and methods validation for drugs and biologics“, it should be continually assured that an analytical procedure remains fit for its intended purpose throughout its application. This includes an ongoing program for routine monitoring of analytical performance data, and the systematic evaluation of changes with the objective to evaluate regularly the need for optimization and revalidation, if needed. These activities belong to stage 3 of the analytical lifecycle management as discussed in the draft of the new USP information chapter . The on-going performance verification is also intended to be included in the revision of the ICH validation guideline Q2.

Target Group

The webinar is aimed at executives and employees from Quality Control, Quality Assurance, and production who want to gain a better understanding of the GMP requirements as well as current discussions with respect to the lifecycle management of analytical procedures and are interested in practical recommendations for an efficient design, execution, and evaluation of a continuous analytical performance verification.

Programme

Besides regulatory expectations, the Webinar provides practical recommendations and orientation for demonstration of the on-going suitability of analytical procedures. In particular, efficient approaches will be presented to extract information and data from routine analysis. This will be illustrated with examples from quality control of chemical drug substances and bio-pharmaceuticals. A comprehensive understanding of the real analytical performance is extremely helpful to investigate and evaluate suspect or out-of specification (OOS) results as well as for a continuous process validation.

The following topics will be covered in the webinar:
  • Regulatory requirements
  • Integration into the analytical lifecycle concept (draft USP information chapter )
  • Benefits of monitoring analytical performance
  • What are the sources of analytical performance information?
  • Risk-based identification of suitable performance parameters (SST, from sample analysis, control samples)
  • Evaluation of information and data (OOS, invalid results, control charts, average parameters)
  • Continual improvements

Duration of the Recording: Appr. 1,5 h

Recording from 30 July 2020

Go back

Recorded GMP Online Training/Webinars by topic

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK